SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Bruno Lawrence

(Last) (First) (Middle)
6316 WINDFERN ROAD

(Street)
HOUSTON TX 77040

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/08/2018
3. Issuer Name and Ticker or Trading Symbol
CORE LABORATORIES N V [ CLB ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 4,287 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Shares (1) (1) Common Shares 600 (1) D
Performance Shares (2)(3) (2)(3) Common Shares 5,400 (2)(3) D
Explanation of Responses:
1. Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the respective grant date. Mr. Bruno has three grants still outstanding, and of those the following shares remain unvested at this time: 200 shares from the grant on 08/01/12; 100 shares from the grant on 09/01/12; and 300 shares from the grant on 04/01/14.
2. Assuming his continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, 3,000 shares would vest at the end of a three-year performance period that began on January 1, 2016 and ends on the last NYSE trading day of December 2018 (the "2016 Performance Period"). 3,000 of the restricted Performance Shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the 2016 Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.
3. Assuming his continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, 2,400 shares would vest at the end of a three-year performance period that began on January 1, 2017 and ends on the last NYSE trading day of December 2019 (the "2017 Performance Period"). 2,400 of the restricted Performance Shares will vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the 2017 Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.
Remarks:
/s/ Mark Elvig, Attorney-in-Fact 02/08/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.